RecruitingNCT03655015

Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer

Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer (CTMS 18-0056)


Sponsor

The University of Texas Health Science Center at San Antonio

Enrollment

150 participants

Start Date

Oct 16, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

Create a living biobank of PDOs from Stage I-III lung cancer patients.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is collecting tumor and blood samples from people with lung cancer to grow miniature replicas of the tumor in the lab (called organoids) and to look for cancer cells circulating in the blood, so researchers can predict which treatments will work best for each patient. **You may be eligible if...** - You have been diagnosed with lung cancer or have a suspicious lung mass or swollen lymph nodes being evaluated - You are scheduled to receive standard treatment (either systemic therapy or surgery) - You are at any stage of lung cancer - You have read and signed the informed consent form **You may NOT be eligible if...** - You are unable or unwilling to provide consent - A tissue sample cannot safely be collected from your tumor - You are not scheduled for any standard treatment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURELung Tumor Resection

Lung Tumor Resection


Locations(1)

UT Health San Antonio, M.D. Anderson Cancer Center

San Antonio, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03655015


Related Trials